From: Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
 | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95%CI | p-value | OR | 95%CI | p-value | |
Age | 1.000 | 0.950–1.053 | 0.998 |  |  |  |
Bdoy mass index | 1.092 | 0.958–1.245 | 0.186 |  |  |  |
DM | 0.937 | 0.303–2.892 | 0.909 |  |  |  |
HTN | 1.273 | 0.645–2.515 | 0.486 |  |  |  |
Prostate volume | 0.981 | 0.960–1.003 | 0.087 |  |  |  |
PSA | 0.936 | 0.824–1.063 | 0.310 |  |  |  |
PSA density | 2.755 | 0.352–21.536 | 0.334 |  |  |  |
PIRADS (< 3 vs. ≥ 3) | 6.940 | 2.788–17.275 |  < 0.001 | 6.246 | 2.400–16.255 |  < 0.001 |
Number of biopsy (12 vs. ≥ 13) | 0.319 | 0.093–1.099 | 0.070 |  |  |  |
Mean percentage of positive core | 1.007 | 0.990–1.025 | 0.431 |  |  |  |
Mean tumor length | 3.667 | 1.493–9.005 | 0.005 | 0.133 | 0.014–1.285 | 0.081 |
Mean percentage of total tumor of core | 1.027 | 1.012–1.041 |  < 0.001 | 1.049 | 1.014–1.086 | 0.006 |